Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can amoxicillin be detected in the aquatic environment? A critical assessment.

Environment international·2026
Same author

Sensory deficiencies correlate with tau protein and dementia.

Frontiers in neuroscience·2026
Same author

Neuronal alkaline phosphatase promotes the spread of Tau-induced pathology, and its blockade prevents neurodegeneration and memory loss.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Performance comparison of microalgae-based and activated sludge with membrane filtration (AS-MBR) for emerging contaminant removal and wastewater reuse.

Journal of hazardous materials·2025
Same author

Structure and function of Full-length Tau.

PloS one·2025
Same author

Amyloid and tau pathologies cross-talk to promote Alzheimeŕs disease: novel mechanistic insights.

Neuroscience·2025

Related Experiment Video

Updated: Mar 3, 2026

Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases
10:38

Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases

Published on: December 22, 2023

1.1K

Neuronal models for studying tau pathology.

Thorsten Koechling1, Filip Lim, Felix Hernandez

  • 1Centro de Biología Molecular "Severo Ochoa" (C.S.I.C.-U.A.M.), Facultad de Ciencias, Universidad Autónoma de Madrid, 28049 Madrid, Spain.

International Journal of Alzheimer'S Disease
|August 20, 2010
PubMed
Summary
This summary is machine-generated.

Animal models of Alzheimer's disease (AD) replicate key brain changes like amyloid plaques and tau tangles. This review examines existing AD models, their pros and cons, and their impact on developing new therapies.

More Related Videos

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
05:51

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

6.5K
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

19.1K

Related Experiment Videos

Last Updated: Mar 3, 2026

Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases
10:38

Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases

Published on: December 22, 2023

1.1K
An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
05:51

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

6.5K
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

19.1K

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Alzheimer's disease (AD) is a leading cause of dementia in aging populations.
  • AD pathology includes brain amyloid plaques and neurofibrillary tangles (NFTs) composed of tau protein.
  • Genetically modified animal models are crucial for studying AD mechanisms.

Purpose of the Study:

  • To review prominent animal models of Alzheimer's disease.
  • To evaluate the advantages and limitations of these models in simulating AD pathology.
  • To discuss findings from these models and their role in AD therapeutic development.

Main Methods:

  • Review of existing literature on genetically modified animal models of AD.
  • Analysis of models simulating key AD hallmarks: beta-amyloid plaques and tau tangles.
  • Evaluation of model utility for understanding disease progression and testing treatments.

Main Results:

  • Various animal models (mouse, fish, worm, fly) successfully replicate AD-like pathology.
  • Each model offers unique insights but also possesses specific shortcomings.
  • Data from these models have informed current understanding and therapeutic strategies for AD.

Conclusions:

  • Animal models are indispensable tools for Alzheimer's disease research.
  • Careful selection and interpretation of model data are essential for progress.
  • Continued refinement of animal models will accelerate the development of effective AD therapies.